Literature DB >> 10407153

Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition.

K Yamasaki1, T Maruyama, K Yoshimoto, Y Tsutsumi, R Narazaki, A Fukuhara, U Kragh-Hansen, M Otagiri.   

Abstract

The relationship between the two principal ligand binding sites, sites I and II, on human serum albumin (HSA) was quantitatively and qualitatively examined by equilibrium dialysis and fluorescence spectroscopy. Among the three subsite markers to site I, only the binding of dansyl-L-asparagine (DNSA), which is a subsite Ib marker (K. Yamasaki et al., Biochim. Biophys. Acta 1295 (1996) 147), was inhibited by the simultaneous binding of a site II ligand, such as ibuprofen and diazepam. This indicates that, in contrast to subsite Ib, subsites Ia and Ic do not strongly interact with site II. The thermodynamic characteristics for the coupling reaction between DNSA and ibuprofen and between DNSA and diazepam, which gave positive coupling free energies and negative values for both coupling enthalpy and entropy, indicated that the reaction process was entropically driven. Increase of pH from 6.5 to 8.2 caused an increase in coupling constant and entropy for the mutual antagonism between DNSA and the site II ligands on binding to HSA. The site II ligand-induced red-shift of lambda(max) and solvent accessibility of DNSA in subsite Ib were decreased when the albumin molecule was isomerized from the neutral (N) to the base (B) conformation in the physiological pH region. Based on these findings, we conclude that a 'competitive' like strong allosteric regulation exists for the binding of these two ligands to the N conformer, whereas for the B conformer this interaction can be classified as nearly 'independent'. Since the distance between Trp-214, which resides within the site I subdomain, and Tyr-411, which is involved in site II, is increased by 6 A during the N-B transition (N.G. Hagag et al., Fed. Proc. 41 (1982) 1189), we propose a mechanism for the pH-dependent antagonistic binding between subsite Ib and site II, which involves the transmission of ligand-induced allosteric effects from one site to another site, modified by changes in the spatial relationship of sites I and II caused by the N-B transition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407153     DOI: 10.1016/s0167-4838(99)00098-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin.

Authors:  Paolo Ascenzi; Alessandro Bolli; Alessandra di Masi; Grazia R Tundo; Gabriella Fanali; Massimo Coletta; Mauro Fasano
Journal:  J Biol Inorg Chem       Date:  2010-09-25       Impact factor: 3.358

2.  Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin.

Authors:  T Sakai; K Yamasaki; T Sako; U Kragh-Hansen; A Suenaga; M Otagiri
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

3.  Evidence for pH-dependent multiple conformers in iron(II) heme-human serum albumin: spectroscopic and kinetic investigation of carbon monoxide binding.

Authors:  Yu Cao; Francesco P Nicoletti; Giampiero De Sanctis; Alessio Bocedi; Chiara Ciaccio; Francesca Gullotta; Gabriella Fanali; Grazia R Tundo; Alessandra di Masi; Mauro Fasano; Giulietta Smulevich; Paolo Ascenzi; Massimo Coletta
Journal:  J Biol Inorg Chem       Date:  2011-09-06       Impact factor: 3.358

4.  Reversible two-step unfolding of heme-human serum albumin: a (1)H-NMR relaxometric and circular dichroism study.

Authors:  Gabriella Fanali; Giampiero De Sanctis; Magda Gioia; Massimo Coletta; Paolo Ascenzi; Mauro Fasano
Journal:  J Biol Inorg Chem       Date:  2008-10-21       Impact factor: 3.358

5.  Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albumin.

Authors:  Paolo Ascenzi; Alessandra di Masi; Massimo Coletta; Chiara Ciaccio; Gabriella Fanali; Francesco P Nicoletti; Giulietta Smulevich; Mauro Fasano
Journal:  J Biol Chem       Date:  2009-09-03       Impact factor: 5.157

6.  Structure, properties, and engineering of the major zinc binding site on human albumin.

Authors:  Claudia A Blindauer; Ian Harvey; Kerry E Bunyan; Alan J Stewart; Darrell Sleep; David J Harrison; Stephen Berezenko; Peter J Sadler
Journal:  J Biol Chem       Date:  2009-06-11       Impact factor: 5.157

7.  A molecular mechanism for modulating plasma Zn speciation by fatty acids.

Authors:  Jin Lu; Alan J Stewart; Darrell Sleep; Peter J Sadler; Teresa J T Pinheiro; Claudia A Blindauer
Journal:  J Am Chem Soc       Date:  2012-01-12       Impact factor: 15.419

8.  Interaction of virstatin with human serum albumin: spectroscopic analysis and molecular modeling.

Authors:  Tanaya Chatterjee; Aritrika Pal; Sucharita Dey; Barun K Chatterjee; Pinak Chakrabarti
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

Review 9.  Heme-based catalytic properties of human serum albumin.

Authors:  P Ascenzi; A di Masi; G Fanali; M Fasano
Journal:  Cell Death Discov       Date:  2015-09-07

10.  Reciprocal allosteric modulation of carbon monoxide and warfarin binding to ferrous human serum heme-albumin.

Authors:  Alessio Bocedi; Giampiero De Sanctis; Chiara Ciaccio; Grazia R Tundo; Alessandra Di Masi; Gabriella Fanali; Francesco P Nicoletti; Mauro Fasano; Giulietta Smulevich; Paolo Ascenzi; Massimo Coletta
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.